Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones
Go back to Arcus Biosciences Provides Update on Clinical Programs, Including Key 2022 Milestones| (NYSE: RCUS) | Delayed: 26.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.15 | 52 Week High | $ | |||
| Open | $26.15 | 52 Week Low | $ | |||
| Day High | $26.15 | P/E | N/A | |||
| Day Low | $26.15 | EPS | $ | |||
| Volume | 22 | |||||
